ASH Highlights

Lenalidomide/Dexamethasone versus Bortezomib/Lenalidomide/Dexamethasone in Newly Diagnosed Multiple Myeloma: Results of the Phase 3 SWOG S0777 Trial

ASH 2015 - Multiple Myeloma, ASH Highlights

Conference Correspondent

Randomized Phase 2 Study of the All-Oral Combination of Ixazomib plus Cyclophosphamide and Low-Dose Dexamethasone (ICd) in Transplant-Ineligible Newly Diagnosed Multiple Myeloma

ASH 2015 - Multiple Myeloma, ASH Highlights

Conference Correspondent

ELOQUENT-2 Update: A Phase 3, Randomized, Open-Label Study of Elotuzumab in Combination with Lenalidomide/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma—3-Year Safety and Efficacy Follow-Up

ASH 2015 - Multiple Myeloma, ASH Highlights

Conference Correspondent

Bortezomib Induction and Maintenance in Patients with Newly Diagnosed Multiple Myeloma: Long-Term Follow-Up of the HOVON-65/GMMG-HD4 Trial

ASH 2015 - Multiple Myeloma, ASH Highlights

Conference Correspondent

Weekly Carfilzomib with Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma (CHAMPION-1)

ASH 2015 - Multiple Myeloma, ASH Highlights

Conference Correspondent

Safety of Pomalidomide/Low-Dose Dexamethasone Treatment in Renally Impaired Patients with Relapsed or Refractory Multiple Myeloma

ASH 2015 - Multiple Myeloma, ASH Highlights

Conference Correspondent

Pomalidomide/Dexamethasone/Ixazomib versus Pomalidomide/Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma: Results of Phase 1/2 Alliance A061202

ASH 2015 - Multiple Myeloma, ASH Highlights

Conference Correspondent

Novel Kinesin Spindle Protein Inhibitor Filanesib Plus Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

ASH 2015 - Multiple Myeloma, ASH Highlights

Conference Correspondent

Ibrutinib plus Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma: Results of an Ongoing Phase 1/2b Study (PCYC-1119)

ASH 2015 - Multiple Myeloma, ASH Highlights

Conference Correspondent

Pembrolizumab plus Lenalidomide/Low-Dose Dexamethasone for Relapsed/Refractory Multiple Myeloma (KEYNOTE-023)

ASH 2015 - Multiple Myeloma, ASH Highlights

Conference Correspondent

Page 7 of 15

4
5
6
7
8
9
10